Morten Albrechtsen
Board member
Clinical development
CombiGene AB
Sweden
Biography
Morten Albrechtsen Born 1964, has a long history of CNS drug development including Alzheimer's disease (for Enkam company), Depression (Boehringer Ingelheim), Newcomed / Saniona, Pain Control (Nycomed), Insomnia Inc. / Sleep Insomnia (Blake Insomnia Inc.) And stroke (Boehringer Ingelheim, Enkam). His experience ranges from preclinical and clinical development to regulatory affairs and commercialization, and includes both biological products and small molecules.
Research Interest
CNS drug development
